Duquesne Family Office – Reata Pharmaceuticals Inc Cl A

Duquesne Family Office ownership history of Reata Pharmaceuticals Inc Cl A
QuarterValueSharesWeighting
Q1 2021$74,765
-19.3%
749,8970.0%1.92%
-23.0%
Q4 2020$92,702
75.0%
749,897
37.9%
2.50%
62.4%
Q3 2020$52,987
-36.3%
543,901
2.1%
1.54%
-39.5%
Q2 2020$83,140
8.3%
532,878
0.2%
2.54%
-18.3%
Q1 2020$76,771
-12.0%
531,878
24.6%
3.11%
21.7%
Q4 2019$87,234
527.0%
426,719
146.3%
2.56%
372.6%
Q3 2019$13,913173,2850.54%